Cytokine blockade in sepsis--Are two better than one?

Crit Care Med. 2001 Mar;29(3):671-2. doi: 10.1097/00003246-200103000-00040.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Animals
  • Antigens, CD / therapeutic use*
  • Critical Care / methods
  • Disease Models, Animal
  • Drug Therapy, Combination
  • Humans
  • Immunotherapy / methods*
  • Inflammation
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1 / antagonists & inhibitors*
  • Mice
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Receptors, Tumor Necrosis Factor, Type I
  • Sepsis / drug therapy*
  • Sepsis / immunology
  • Sialoglycoproteins / therapeutic use*
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antigens, CD
  • IL1RN protein, human
  • Il1rn protein, mouse
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1
  • Receptors, Tumor Necrosis Factor
  • Receptors, Tumor Necrosis Factor, Type I
  • Sialoglycoproteins
  • Tumor Necrosis Factor-alpha